BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• BioCapital

  Rexahn Pharmaceuticals, Inc. Granted European Patent for Novel Anti-cancer Isoquinolinamine Compounds

  September 26, 2012

   · 

  1 min read
• Business

  AusBiotech Ltd. & Beacon to Partner on Key Investment Events

  September 26, 2012

   · 

  3 min read
• Business

  Ioxus Recruits Ken Rudisuela for Chief Technology Officer Post

  September 26, 2012

   · 

  1 min read
• Pharm Country

  Janssen Research & Development and Johnson & Johnson to Present Latest Phase 3 Results for Canagliflozin in the Treatment of Patients With Type 2 Diabetes

  September 26, 2012

   · 

  1 min read
• Business

  ICON-PLC Strengthens Leadership Teams in Asia Pacific and Latin America

  September 26, 2012

   · 

  2 min read
• BioCapital

  Protein Potential LLC Awarded $1.8 Million to Develop Multi-Component New Malaria Vaccine Solution

  September 26, 2012

   · 

  3 min read
• Business

  Aethlon Medical Announces the Appointment of Dr. Stephen Z. Fadem to its Extracorporeal Science Advisory Board

  September 26, 2012

   · 

  4 min read
• BioMidwest

  Improved Genomic Target Selection Using Integrated DNA Technologies Oligos

  September 26, 2012

   · 

  2 min read
• FDA

  OrthoAccel® Technologies, Inc. Receives Clearance From Korean Food and Drug Administration for AcceleDent™

  September 26, 2012

   · 

  1 min read
• Drug Development

  Boehringer Ingelheim Pharmaceuticals, Inc. Completes Enrollment of Pivotal Phase III Studies for Nintedanib (BIBF 1120) in Idiopathic Pulmonary Fibrosis

  September 26, 2012

   · 

  6 min read